European Patent Office reaches positive decision on Feraccru®’s process patent

14 Mar 2019

 

Shield Therapeutics plc, announces that, further to the announcement on 24 January 2019 and in relation to the Group’s patent #2 668 175, which covers a “Process for preparing an iron hydroxypyrone”, the Opposition Division of the European Patent Office (EPO) has today decided in favour of Shield.

For further information please click here.

Back to news